Geneos Wealth Management Inc. Sells 57,711 Shares of CVS Health Co. (NYSE:CVS)

Geneos Wealth Management Inc. lessened its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 90.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,757 shares of the pharmacy operator's stock after selling 57,711 shares during the quarter. Geneos Wealth Management Inc.'s holdings in CVS Health were worth $258,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. apricus wealth LLC raised its holdings in CVS Health by 2.1% during the 4th quarter. apricus wealth LLC now owns 37,055 shares of the pharmacy operator's stock valued at $1,663,000 after buying an additional 765 shares during the last quarter. Exchange Traded Concepts LLC grew its stake in shares of CVS Health by 17.9% in the fourth quarter. Exchange Traded Concepts LLC now owns 17,514 shares of the pharmacy operator's stock worth $786,000 after purchasing an additional 2,661 shares during the last quarter. CX Institutional raised its position in CVS Health by 35.1% during the 4th quarter. CX Institutional now owns 100,787 shares of the pharmacy operator's stock valued at $4,524,000 after purchasing an additional 26,178 shares during the last quarter. Southland Equity Partners LLC lifted its holdings in CVS Health by 44.0% in the 4th quarter. Southland Equity Partners LLC now owns 4,985 shares of the pharmacy operator's stock worth $224,000 after buying an additional 1,523 shares during the period. Finally, Secure Asset Management LLC increased its stake in shares of CVS Health by 13.8% during the fourth quarter. Secure Asset Management LLC now owns 33,271 shares of the pharmacy operator's stock valued at $1,494,000 after buying an additional 4,024 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CVS. Truist Financial cut their price target on shares of CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Mizuho reduced their price target on CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research note on Thursday, October 24th. Evercore ISI upped their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research report on Monday. StockNews.com cut shares of CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Finally, Wells Fargo & Company raised CVS Health from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and a consensus price target of $68.12.

CVS Health Trading Down 0.9 %

Shares of CVS traded down $0.51 during midday trading on Thursday, hitting $56.39. The stock had a trading volume of 4,948,186 shares, compared to its average volume of 13,187,066. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market cap of $70.96 billion, a P/E ratio of 14.30, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The business has a 50-day simple moving average of $51.28 and a two-hundred day simple moving average of $56.17.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the prior year, the company earned $2.21 EPS. The firm's quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.72%. The ex-dividend date is Thursday, January 23rd. CVS Health's dividend payout ratio is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.